Using external data to improve cancer clinical trials
Statistical Methods and Validation Analyses for the Integration of External Data in Clinical Trials
This study is looking at how to use information from past cancer studies and real-life patient data to make clinical trials for brain cancer and other types of cancer better and faster, which could help get new treatments to patients sooner.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10757723 on NIH RePORTER |
What this research studies
This research investigates how to incorporate external data from previous clinical studies and real-world datasets into the design and analysis of oncology trials, particularly for conditions like glioblastoma. By developing new statistical methodologies, the project aims to enhance decision-making during trials, such as determining when to stop a trial early based on interim results. The goal is to reduce the number of patients needed for trials and shorten their duration, ultimately accelerating the development of new cancer treatments. The research will focus on datasets related to prostate cancer, glioblastoma, and lung cancer, ensuring that the integration of external data is both effective and reliable.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma or other cancers included in the study, such as prostate cancer and lung cancer.
Not a fit: Patients with cancers not included in the datasets or those who are not eligible for clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more efficient clinical trials, resulting in quicker access to new treatments for cancer patients.
How similar studies have performed: Previous research has shown promise in using external data to enhance clinical trial designs, indicating that this approach could be effective.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Trippa, Lorenzo — Dana-Farber Cancer Inst
- Study coordinator: Trippa, Lorenzo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.